|
1
|
World Health Organization (WHO): Novel
coronavirus (2019-nCoV) situation report-1. urihttps://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4simplehttps://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4.
Accessed January 21, 2020.
|
|
2
|
He F, Deng Y and Li W: Coronavirus disease
2019: What we know? J Med Virol. 92:719–725. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cui J, Li F and Shi ZL: Origin and
evolution of pathogenic coronaviruses. Nat Rev Microbiol.
17:181–192. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Liu Y, Yan LM, Wan L, Xiang TX, Le A, Liu
JM, Peiris M, Poon LLM and Zhang W: Viral dynamics in mild and
severe cases of COVID-19. Lancet Infect Dis. 20:656–657.
2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng
Q, Meredith HR, Azman AS, Reich NG and Lessler J: The incubation
period of coronavirus disease 2019 (CoVID-19) from publicly
reported confirmed cases: Estimation and application. Ann Intern
Med. 172:577–582. 2020.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Pan F, Ye T, Sun P, Gui S, Liang B, Li L,
Zheng D, Wang J, Hesketh RL, Yang L and Zheng C: Time course of
lung changes on chest CT during recovery from 2019 novel
coronavirus (covid-19) pneumonia. Radiology. 295:715–721.
2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Takeuchi Y, Furuchi M, Kamimoto A, Honda
K, Matsumura H and Kobayashi R: Saliva-based PCR tests for
SARS-CoV-2 detection. J Oral Sci. 62:350–351. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Pascarella G, Strumia A, Piliego C, Bruno
F, Del Buono R, Costa F, Scarlata S and Agrò FE: COVID-19 diagnosis
and management: A comprehensive review. J Intern Med. 288:192–206.
2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Winter AK and Hegde ST: The important role
of serology for COVID-19 control. Lancet Infect Dis. 20:758–759.
2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Deeks JJ, Dinnes J, Takwoingi Y, Davenport
C, Spijker R, Taylor-Phillips S, Adriano A, Beese S, Dretzke J,
Ferrante di Ruffano L, et al: Antibody tests for identification of
current and past infection with SARS-CoV-2. Cochrane database Syst
Rev. 6(CD013652)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Dignani MC, Costantini P, Salgueira C,
Jordán R, Guerrini G, Valledor A, Herrera F, Nenna A, Mora C,
Roccia-Rossi I, et al: Pandemic 2009 influenza A (H1N1) virus
infection in cancer and hematopoietic stem cell transplant
recipients; a multicenter observational study. F1000Res.
3(221)2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Liang W, Guan W, Chen R, Wang W, Li J, Xu
K, Li C, Ai Q, Lu W, Liang H, et al: Cancer patients in SARS-CoV-2
infection: A nationwide analysis in China. Lancet Oncol.
21:335–337. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yu J, Ouyang W, Chua MLK and Xie C:
SARS-CoV-2 transmission in patients with cancer at a tertiary care
hospital in Wuhan, China. JAMA Oncol. 6:1108–1110. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wu Z and McGoogan JM: Characteristics of
and important lessons from the coronavirus disease 2019 (COVID-19)
outbreak in China: Summary of a report of 72 314 cases from the
Chinese center for disease control and prevention. JAMA.
323:1239–1242. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
World Health Organization (WHO):
Coronavirus disease (2019-COVID-19) technical guidance: Patient
management. urihttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/patient-managementsimplehttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/patient-management.
|
|
17
|
Centers for Disease Control And
Prevention. Interim clinical guidance for management of patients
with confirmed coronavirus disease (COVID-19).
|
|
18
|
Andersen KG, Rambaut A, Lipkin WI, Holmes
EC and Garry RF: The proximal origin of SARS-CoV-2. Nat Med.
26:450–452. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Li F: Structure, function, and evolution
of coronavirus spike proteins. Annu Rev Virol. 3:237–261.
2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhou P, Yang XL, Wang XG, Hu B, Zhang L,
Zhang W, Si HR, Zhu Y, Li B, Huang CL, et al: A pneumonia outbreak
associated with a new coronavirus of probable bat origin. Nature.
579:270–273. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song
ZG, Hu Y, Tao ZW, Tian JH, Pei YY, et al: A new coronavirus
associated with human respiratory disease in China. Nature.
579:265–269. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wan Y, Shang J, Graham R, Baric RS and Li
F: Receptor recognition by the novel coronavirus from Wuhan: An
analysis based on decade-long structural studies of SARS
coronavirus. J Virol. 94:e00127–20. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan
B, Huan Y, Yang P, Zhang Y, Deng W, et al: A crucial role of
angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced
lung injury. Nat Med. 11:875–879. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Walls AC, Park YJ, Tortorici MA, Wall A,
McGuire AT and Veesler D: Structure, function, and antigenicity of
the SARS-CoV-2 spike glycoprotein. Cell. 181:281–292.e6.
2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wang Q, Zhang Y, Wu L, Niu S, Song C,
Zhang Z, Lu G, Qiao C, Hu Y, Yuen KY, et al: Structural and
functional basis of SARS-CoV-2 entry by using human ACE2. Cell.
181:894–904.e9. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Hamming I, Timens W, Bulthuis MLC, Lely
AT, Navis GJ and van Goor H: Tissue distribution of ACE2 protein,
the functional receptor for SARS coronavirus. A first step in
understanding SARS pathogenesis. J Pathol. 203:631–637.
2004.PubMed/NCBI View Article : Google Scholar
|
|
27
|
White JM and Whittaker GR: Fusion of
enveloped viruses in endosomes. Traffic. 17:593–614.
2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang H, Yang P, Liu K, Guo F, Zhang Y,
Zhang G and Jiang C: SARS coronavirus entry into host cells through
a novel clathrin- and caveolae-independent endocytic pathway. Cell
Res. 18:290–301. 2008.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Matsuyama S, Ujike M, Morikawa S, Tashiro
M and Taguchi F: Protease-mediated enhancement of severe acute
respiratory syndrome coronavirus infection. Proc Natl Acad Sci USA.
102:12543–12547. 2005.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hoffmann M, Kleine-Weber H, Schroeder S,
Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH,
Nitsche A, et al: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2
and is blocked by a clinically proven protease inhibitor. Cell.
181:271–280.e8. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Sungnak W, Huang N, Bécavin C, Berg M,
Queen R, Litvinukova M, Talavera-López C, Maatz H, Reichart D,
Sampaziotis F, et al: SARS-CoV-2 entry factors are highly expressed
in nasal epithelial cells together with innate immune genes. Nat
Med. 26:681–687. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng
X, Li T and Chen Q: High expression of ACE2 receptor of 2019-nCoV
on the epithelial cells of oral mucosa. Int J Oral Sci.
12(8)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zou X, Chen K, Zou J, Han P, Hao J and Han
Z: Single-cell RNA-seq data analysis on the receptor ACE2
expression reveals the potential risk of different human organs
vulnerable to 2019-nCoV infection. Front Med. 14:185–192.
2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Pinto BGG, Oliveira AER, Singh Y, Jimenez
L, Gonçalves ANA, Ogava RLT, Creighton R, Schatzmann Peron JP and
Nakaya HI: ACE2 expression is increased in the lungs of patients
with comorbidities associated with severe COVID-19. J Infect Dis.
222:556–563. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Ciaglia E, Vecchione C and Puca AA:
COVID-19 infection and circulating ACE2 levels: Protective role in
women and children. Front Pediatr. 8(206)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Coutard B, Valle C, de Lamballerie X,
Canard B, Seidah NG and Decroly E: The spike glycoprotein of the
new coronavirus 2019-nCoV contains a furin-like cleavage site
absent in CoV of the same clade. Antiviral Res.
176(104742)2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Lukassen S, Chua RL, Trefzer T, Kahn NC,
Schneider MA, Muley T, Winter H, Meister M, Veith C, Boots AW, et
al: SARS -CoV-2 receptor ACE 2 and TMPRSS 2 are primarily expressed
in bronchial transient secretory cells. EMBO J.
39(e105114)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Gupta I, Rizeq B, Elkord E, Vranic S and
Moustafa AE: Sars-cov-2 infection and lung cancer: Potential
therapeutic modalities. Cancers (Basel). 12(2186)2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Mehta P, McAuley DF, Brown M, Sanchez E,
Tattersall RS and Manson JJ: HLH Across Speciality Collaboration,
UK. COVID-19: Consider cytokine storm syndromes and
immunosuppression. Lancet. 395:1033–1034. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
José Alencar Gomes da Silva National
Cancer Institute/Ministry of Health: Estimate/2020-Cancer Incidence
in Brazil. urihttps://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2020-incidencia-de-cancer-no-brasil.pdfsimplehttps://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2020-incidencia-de-cancer-no-brasil.pdf.
|
|
41
|
de Groot PM, Wu CC, Carter BW and Munden
RF: The epidemiology of lung cancer. Transl Lung Cancer Res.
7:220–233. 2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Zappa C and Mousa SA: Non-small cell lung
cancer: Current treatment and future advances. Transl Lung Cancer
Res. 5:288–300. 2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Zhang L, Zhu F, Xie L, Wang C, Wang J,
Chen R, Jia P, Guan HQ, Peng L, Chen Y, et al: Clinical
characteristics of COVID-19-infected cancer patients: A
retrospective case study in three hospitals within Wuhan, China.
Ann Oncol. 31:894–901. 2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Kong Q, Xiang Z, Wu Y, Gu Y, Guo J and
Geng F: Analysis of the susceptibility of lung cancer patients to
SARS-CoV-2 infection. Mol Cancer. 19(80)2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899.
2010.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Li X, Liu M, Zhao Q, Liu R, Zhang H, Dong
M, Xu S, Zhao H, Wei S, Song Z, et al: Preliminary recommendations
for lung surgery during SARS-CoV-2 novel coronavirus pneumonia
epidemic period. Zhongguo Fei Ai Za Zhi. 23:133–135.
2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
47
|
de Marinis F, Attili I, Morganti S, Stati
V, Spitaleri G, Gianoncelli L, Del Signore E, Catania C, Rampinelli
C, Omodeo Salè E, et al: Results of multilevel containment measures
to better protect lung cancer patients from COVID-19: The IEO
model. Front Oncol. 10(665)2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Kumar S, Chmura S, Robinson C, Lin SH,
Gadgeel SM, Donington J, Feliciano J, Stinchcombe TE, Werner-Wasik
M, Edelman MJ and Moghanaki D: Alternative multidisciplinary
management options for locally advanced nsclc during the
coronavirus disease 2019 global pandemic. J Thorac Oncol.
15:1137–1146. 2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Li X, Zeng W, Li X, Chen H, Shi L, Li X,
Xiang H, Cao Y, Chen H, Liu C and Wang J: CT imaging changes of
corona virus disease 2019(COVID-19): A multi-center study in
Southwest China. J Transl Med. 18(154)2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Moazzami B, Razavi-Khorasani N, Dooghaie
Moghadam A, Farokhi E and Rezaei N: COVID-19 and telemedicine:
Immediate action required for maintaining healthcare providers
well-being. J Clin Virol. 126(104345)2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Calton B, Abedini N and Fratkin M:
Telemedicine in the time of coronavirus. J Pain Symptom Manage.
60:e12–e14. 2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Brazilian Society of Clinical Oncology
(SBOC): SBOC Positioning - Coronavirus (COVID-19). urihttps://sboc.org.br/noticias/item/1797-posicionamesimplehttps://sboc.org.br/noticias/item/1797-posicioname.
Accessed March 12, 2020.
|
|
53
|
Poder Legislativo: Diário Oficial da
União. urihttps://www.in.gov.br/web/dou/-/lei-n-13.989-de-15simplehttps://www.in.gov.br/web/dou/-/lei-n-13.989-de-15.
2020 (In Portuguese).
|
|
54
|
Li MY, Li L, Zhang Y and Wang XS:
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide
variety of human tissues. Infect Dis Poverty. 9(45)2020.PubMed/NCBI View Article : Google Scholar
|
